Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Turning Point Therapeutics Inc (TPTX)
NASDAQ:TPTX
Turning Point Therapeutics (TPTX) Ownership - Who Owns Turning Point Therapeutics?
0 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 29, 2022 | Tombesi Paolo Evp & Cfo | Sold | |
| Feb 11, 2022 | Reich Siegfried Evp & Chief Scientific Officer | Sold | |
| Feb 11, 2022 | Annette North Evp & Gc | Sold |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2022 | Bought | $1847989 | |
| Jun 30, 2022 | Bought | $1881250 | |
| Jun 30, 2022 | Bought | $31139052 | |
| Jun 30, 2022 | Bought | $31228750 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Turning Point Therapeutics Inc (TPTX)?
Currently, no data Available
What percentage of Turning Point Therapeutics Inc (TPTX) stock is held by institutional investors?
Currently, no data Available
What percentage of Turning Point Therapeutics Inc (TPTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Turning Point Therapeutics Inc (TPTX)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.